Trials / Active Not Recruiting
Active Not RecruitingNCT06561958
Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings
Prospective, Multi-country, Non-Interventional Study to Investigate REKOVELLE for Ovarian Stimulation: the Effectiveness, Safety, and Patterns Of Use for Asian Women in Real World Practice
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- —
Summary
Primary objective is to investigate the effectiveness of REKOVELLE® in women undergoing their first REKOVELLE® ovarian stimulation treatment in real world practice in Asian countries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | REKOVELLE | Individualised dosing regiment of REKOVELLE in routine clinical practice. |
Timeline
- Start date
- 2024-08-27
- Primary completion
- 2027-05-01
- Completion
- 2027-08-01
- First posted
- 2024-08-20
- Last updated
- 2026-02-17
Locations
31 sites across 5 countries: Japan, South Korea, Taiwan, Thailand, Vietnam
Source: ClinicalTrials.gov record NCT06561958. Inclusion in this directory is not an endorsement.